Aridana Sandika IM, Sastrawan MO, Arsa Wibawa NGB. Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions. Bioscmed. 2026;10(10):2896-2908. doi:10.37275/bsm.v10i10.1658